Related Experiment Video

Updated: May 22, 2026

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

Growth of infant fecal bacteria on commercial prebiotics

Věra Bunešová1, Eva Vlková, Vojtěch Rada

  • 1Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, 165 21, Prague 6, Czech Republic.

Folia Microbiologica
|April 25, 2012
PubMed

Insights

Commercial prebiotics like fructooligosaccharides (FOS) and galactooligosaccharides (GOS) supported fecal bacteria growth in infants. While bifidobacteria and lactobacilli were favored in some, other bacteria also grew, indicating prebiotics may not be fully selective.

Area of Science:

  • Microbiology
  • Infant Gut Microbiome
  • Nutritional Science

Background:

  • The infant gut microbiome plays a crucial role in health and development.
  • Prebiotics are non-digestible food ingredients that selectively stimulate beneficial bacteria.
  • Understanding prebiotic effects on the infant gut is essential for targeted nutritional interventions.

Purpose of the Study:

  • To evaluate the in vitro growth-promoting effects of commercial prebiotics (fructooligosaccharides and galactooligosaccharides) on infant fecal bacteria.
  • To compare the selectivity of prebiotics towards beneficial bacteria (Bifidobacteria, Lactobacilli) versus other fecal bacteria.
  • To assess the influence of birth mode (vaginal vs. caesarean section) on infant fecal microbiota response to prebiotics.

Main Methods:

  • Fecal samples from 33 infants (1-6 months) were analyzed.
  • Bacteria were enumerated using selective agars and fluorescence in situ hybridization (FISH).
  • Inoculated fecal bacteria into media with 2% galactooligosaccharides (GOS) or fructooligosaccharides (FOS) for 24h anaerobic cultivation.

Main Results:

  • Bifidobacteria dominated in infants with naturally high counts, regardless of prebiotic type (GOS or FOS).
  • Prebiotics supported growth of all tested bacterial groups, including Clostridia in bifidobacteria-negative samples.
  • No significant differences in bacterial growth were observed between GOS and FOS, or between cultivation and FISH methods.

Conclusions:

  • Commercial fructooligosaccharides (FOS) and galactooligosaccharides (GOS) support the growth of a broad range of infant fecal bacteria.
  • While bifidobacteria are promoted in infants with pre-existing high levels, prebiotics may not exclusively stimulate desirable bacteria.
  • Further research is needed to develop prebiotics with enhanced selectivity for beneficial infant gut microbes.

More Related Videos

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems06:58

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...